ELEV
Price
$0.63
Change
-$0.04 (-5.97%)
Updated
Dec 18, 04:59 PM (EDT)
76 days until earnings call
PRTC
Price
$21.05
Change
-$0.75 (-3.44%)
Updated
Dec 18, 04:43 PM (EDT)
Ad is loading...

ELEV vs PRTC

Header iconELEV vs PRTC Comparison
Open Charts ELEV vs PRTCBanner chart's image
Elevation Oncology
Price$0.63
Change-$0.04 (-5.97%)
Volume$933
CapitalizationN/A
PureTech Health
Price$21.05
Change-$0.75 (-3.44%)
Volume$100
CapitalizationN/A
ELEV vs PRTC Comparison Chart
Loading...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELEV vs. PRTC commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELEV is a Hold and PRTC is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ELEV: $0.67 vs. PRTC: $21.80)
Brand notoriety: ELEV and PRTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELEV: 99% vs. PRTC: 226%
Market capitalization -- ELEV: $39.6M vs. PRTC: $486.89M
ELEV [@Biotechnology] is valued at $39.6M. PRTC’s [@Biotechnology] market capitalization is $486.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELEV’s FA Score shows that 1 FA rating(s) are green whilePRTC’s FA Score has 1 green FA rating(s).

  • ELEV’s FA Score: 1 green, 4 red.
  • PRTC’s FA Score: 1 green, 4 red.
According to our system of comparison, both ELEV and PRTC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELEV’s TA Score shows that 6 TA indicator(s) are bullish while PRTC’s TA Score has 5 bullish TA indicator(s).

  • ELEV’s TA Score: 6 bullish, 4 bearish.
  • PRTC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ELEV is a better buy in the short-term than PRTC.

Price Growth

ELEV (@Biotechnology) experienced а -10.11% price change this week, while PRTC (@Biotechnology) price change was -3.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

ELEV is expected to report earnings on Mar 05, 2025.

PRTC is expected to report earnings on Nov 27, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTC($487M) has a higher market cap than ELEV($39.6M). ELEV YTD gains are higher at: 24.730 vs. PRTC (-22.640). ELEV has higher annual earnings (EBITDA): -43.11M vs. PRTC (-53.65M). PRTC has more cash in the bank: 502M vs. ELEV (103M). PRTC has less debt than ELEV: PRTC (24M) vs ELEV (31M). ELEV (0) and PRTC (0) have equivalent revenues.
ELEVPRTCELEV / PRTC
Capitalization39.6M487M8%
EBITDA-43.11M-53.65M80%
Gain YTD24.730-22.640-109%
P/E RatioN/AN/A-
Revenue00-
Total Cash103M502M21%
Total Debt31M24M129%
TECHNICAL ANALYSIS
Technical Analysis
ELEVPRTC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
OKYO1.090.05
+4.80%
OKYO Pharma Limited
A136.46-1.21
-0.88%
Agilent Technologies
RYN27.79-0.48
-1.68%
Rayonier
STEL30.25-0.74
-2.39%
Stellar Bancorp

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and RLMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and RLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
-1.58%
RLMD - PRTC
31%
Poorly correlated
-6.97%
CYTK - PRTC
30%
Poorly correlated
-2.53%
PTCHF - PRTC
29%
Poorly correlated
N/A
ELEV - PRTC
26%
Poorly correlated
+4.66%
IMUX - PRTC
26%
Poorly correlated
-1.80%
More